ArticleThe oncologist2020

Real-World Treatment Patterns and Progression-Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non-Small Cell Lung Cancer.

Mohammad Jahanzeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.